Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia.

Autor: Ekor M; Department of Pharmacology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana., Owusu Agyei PE; Department of Pharmacology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana., Obese E; School of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana., Biney RP; School of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana., Henneh IT; School of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana., Antwi-Adjei M; Department of Pharmacology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana., Yahaya ES; Department of Pharmacology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana., Amoakohene G; Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana., Akakpo PK; Department of Pathology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2021 Aug 17; Vol. 16 (8), pp. e0247735. Date of Electronic Publication: 2021 Aug 17 (Print Publication: 2021).
DOI: 10.1371/journal.pone.0247735
Abstrakt: Hyperlipidaemia is a major risk factor for cardiovascular diseases, the leading cause of death globally. Celecoxib attenuated hypercholesterolaemia associated with CCl4-induced hepatic injury in rats without improving liver function in our previous study. This present study investigated the lipid lowering potential of celecoxib in normal rats fed with coconut oil subjected to five deep-frying episodes. Male Sprague Dawley rats were randomly assigned to groups (n = 6 rats/group) which received physiological saline (10 mL/kg), unheated coconut oil (UO, 10 mL/kg) or heated coconut oil (HO, 10 ml/kg) for 60 days. Groups that received HO were subsequently treated with either physiological saline, atorvastatin (25 mg/kg), celecoxib (5 mg/kg) or celecoxib (10 mg/kg) in the last fifteen days of the experiment. Rats were sacrificed 24 hours after last treatment and blood and tissue samples collected for analysis. HO consumption produced significant hyperlipidaemia and elevation in marker enzymes of hepatic function. Celecoxib ameliorated the hyperlipidaemia as shown by the significantly (P<0.05) lower total cholesterol, triglycerides, low and very low density lipoprotein in the celecoxib-treated rats when compared with HO-fed rats that received saline. Celecoxib also reduced (P<0.05) alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and liver weight of hyperlipidaemic rats. Similarly, hepatocellular damage with the hyperlipidaemia was significantly reversed by celecoxib. However, serum TNF-α and IL-6 did not change significantly between the various groups. Taken together, data from this study suggest that celecoxib may exert therapeutic benefit in hyperlipidaemia and its attendant consequences.
Competing Interests: The authors have declared that no competing interests exist.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje